A rat enzyme study found that several organophosphates did not produce one uniform effect on drug-metabolizing pathways.
The investigators studied liver CYP activity after repeated oral organophosphate administration and also added compounds directly to enzyme assays. Midazolam hydroxylation served as a CYP3A reaction. Fenitrothion reduced CYP3A activity after oral exposure, while direct inhibitory potency differed substantially among the chemicals and pathways tested.
The findings show why a chemical family name is insufficient to predict metabolism. Direct enzyme inhibition and changes after repeated whole-animal exposure need not have identical explanations. The study did not measure human midazolam toxicity or establish that pesticide exposure caused prolonged sedation in a patient. Compound identity, exposure magnitude, route, timing, and species remain essential. Its contribution is a differentiated laboratory interaction signal, rather than a universal claim that all organophosphates slow benzodiazepine elimination.
Original analysis of the supplied journal article, identified as PMC7273600.